Clinical Trial Update: Cannabis and Schizophrenia: Self-Medication and Agonist Treatment [Phase 1]

View source ↗

Summary

Phase 1 clinical trial exploring cannabis use in schizophrenia for self-medication and agonist treatment; completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder
• Schizophrenia

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Schizophrenia, Dual Diagnosis | Phase 1 | Status: COMPLETED | Results posted: 2014-09-29